Correlation Between 3D Echocardiography and Cardiopulmonary Exercise Testing in Patients With Single Ventricle
VU3D
1 other identifier
observational
33
1 country
1
Brief Summary
Congenital heart disease (CHD) is the leading cause of birth defects, with an incidence of 0.8%. Among CHD, univentricular heart disease or "single ventricle" is rare and complex. As a result of the improved patient care over the last decades, the number of children and adults with single ventricle is increasing significantly. Today, the main challenge is to ensure an optimal follow-up of these new patients in order to improve their life expenctancy as well as their quality of life (QoL). Currently, echocardiography and cardiopulmonary exercice test (CPET) are central in management of patients with single ventricle as part of good clinical practice guidelines. Single ventricle volumes and function are very difficult to asses with conventional echocardiography because of their complex geometry. Indeed, single ventricle size and morphology vary depending on the patient characteristics and on the initial CHD (before surgical repair). That's why conventional 2D echocardiographic parameters are not reliable for single ventricle assessment. Magnetic resonance imaging (MRI) is more effective in assessing single ventricle volumes and function. Nevertheless, MRI is not universally available, is not practical in many situations, is expensive, and is a relative contraindication in patients with pacemakers. Over the past decade, the use of the 3D echocardiography has increased. This is an available tool that can assess ventricular function and volumes in few seconds. Recent studies shown a good correlation between 3D echocardiography and MRI for assessment of ventricular volumes and function in patient with CHD and especially in those with single ventricle. Moreover, according to some authors, CPET parameters are strongly correlated with risk of hospitalization, risk of death, physical activity and quality of life, especially in patients with single ventricle. To date, there is no study performed about the relationship between 3D echocardiography and CPET parameters in patients with single ventricle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
July 19, 2021
CompletedFirst Posted
Study publicly available on registry
November 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedOctober 27, 2023
October 1, 2023
1.1 years
July 19, 2021
October 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association between single ventricle volumes and function parameters in 3D echocardiography
Association between single ventricle volumes and function parameters in 3D echocardiography (End-diastolic volume, End-systolic volume, Stroke volume)
day 1
Secondary Outcomes (6)
Association between 3D echocardiography and clinical data collected
day 1
Association between 3D echocardiography and quality of life data usually collected
day 1
ssociation between 3D echocardiography and 2D echocardiography data usually collected
day 1
Association between 3D echocardiography and blood test data usually collected.
day 1
Association between 3D echocardiography and MRI data usually collected.
day 1
- +1 more secondary outcomes
Eligibility Criteria
Patients with a single ventricle or univentricular heart
You may qualify if:
- Patient over 8 years old with univentricular heart disease as defined by the ACC-CHD classification
- Agreement from adults or parents if minor patients
- CPET performed within the 6 months before or after performing echocardiography
You may not qualify if:
- Cardiomyopathy unrelated to CHD (eg coronary artery disease, toxic cardiomyopathy)
- Significant clinical status change between performing CPET and performing echocardiography, according to the investigator's opinion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Montpellierlead
- University Hospital, Bordeauxcollaborator
Study Sites (1)
Uh Montpellier
Montpellier, 34295, France
Related Publications (1)
Femenia V, Pommier V, Huguet H, Iriart X, Picot MC, Bredy C, Lorca L, De La Villeon G, Guillaumont S, Pasquie JL, Matecki S, Roubertie F, Leobon B, Thambo JB, Jalal Z, Thomas J, Mouton JB, Avesani M, Amedro P. Correlation between three-dimensional echocardiography and cardiopulmonary fitness in patients with univentricular heart: A cross-sectional multicentre prospective study. Arch Cardiovasc Dis. 2023 Apr;116(4):202-209. doi: 10.1016/j.acvd.2023.02.002. Epub 2023 Mar 9.
PMID: 36966111BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pascal AMEDRO, MD-PhD
UH MONTPELLIER
- PRINCIPAL INVESTIGATOR
Valentin FEMENIA, resident
UH MONTPELLIER
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2021
First Posted
November 11, 2021
Study Start
June 1, 2021
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
October 27, 2023
Record last verified: 2023-10